{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T18:02:23Z","timestamp":1781028143450,"version":"3.54.1"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2025ER200600"],"award-info":[{"award-number":["2025ER200600"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"crossref","award":["2025E200100"],"award-info":[{"award-number":["2025E200100"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tuberculosis preventive treatment (TPT) is essential for tuberculosis elimination; however, evidence on its safety and feasibility in medically complex, high-risk populations is limited. Concerns regarding adverse events frequently hinder treatment initiation and completion in routine clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The Safety of Preventive Treatment in People at Risk for Tuberculosis (STEP-TB) study aims to generate real-world evidence on the safety of TPT among individuals at high risk of developing active tuberculosis disease and to identify factors associated with adverse events, treatment initiation, adherence, and completion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>STEP-TB is a multicenter, prospective observational cohort study conducted at four university-affiliated hospitals in the Republic of Korea. Adults aged \u226519 years who are eligible for latent tuberculosis infection (LTBI) testing or TPT according to national guidelines will be enrolled, including individuals with chronic kidney disease, chronic lung disease, diabetes mellitus, immunosuppressive conditions, malignancy, or occupational risk. LTBI testing will be performed using interferon-gamma release assays, and TPT regimens will follow national guidelines. Participants initiating TPT will be followed for up to 12 months from treatment initiation. Those with negative LTBI results or without TPT will be also followed for up to 12 months. Adverse events, treatment adherence, and completion will be systematically assessed. Blood samples, including volumetric absorptive microsampling, will be collected in a subset of participants for pharmacokinetic and pharmacogenetic analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>The primary outcome is the occurrence of adverse events during TPT. Secondary outcomes include TPT completion rates, predictors of non-initiation and discontinuation, and progression to active TB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>STEP-TB will provide condition-specific, real-world evidence on TPT safety and implementation, informing clinical decision-making, patient-centered care, and national TB control policies to support the safe expansion of LTBI treatment strategies in Korea.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>CRIS Registration Number:<\/jats:bold>\n                      KCT0011063\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0350186","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:28:11Z","timestamp":1781026091000},"page":"e0350186","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Study on the safety evaluation of latent tuberculosis treatment in high\u2011risk groups for tuberculosis development: Study protocol for a multi\u2011center prospective observational cohort study in Korea (STEP-TB)"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3221-0466","authenticated-orcid":true,"given":"Yunkyeong","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonhee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Yun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoolwon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen R.","family":"Stagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4433-231X","authenticated-orcid":true,"given":"Ju Sang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6091-518X","authenticated-orcid":true,"given":"Jinsoo","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"3","key":"pone.0350186.ref001","doi-asserted-by":"crossref","first-page":"606","DOI":"10.4046\/trd.2025.0022","article-title":"Tuberculosis Notification and Incidence: Republic of Korea, 2023","volume":"88","author":"J Min","year":"2025","journal-title":"Tuberc Respir Dis"},{"issue":"3","key":"pone.0350186.ref002","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4046\/trd.2025.0020","article-title":"Tuberculosis Care Quality Assessment: Evaluating Diagnosis and Treatment Effectiveness in Korea, 2018 to 2022","volume":"88","author":"Korean TB and NTM Research Group in The Korean Academy of Tuberculosis and Respiratory Diseases (KATRD)","year":"2025","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"4","key":"pone.0350186.ref003","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4046\/trd.2024.0022","article-title":"Public-Private Partnership for TB Care and Prevention in Korea","volume":"87","author":"J Min","year":"2024","journal-title":"Tuberculosis and Respiratory Diseases"},{"issue":"1","key":"pone.0350186.ref004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4046\/trd.2024.0122","article-title":"Diagnosis and Treatment of Latent Tuberculosis Infection in Adults in South Korea","volume":"88","author":"Korean TB Guideline Development Committee","year":"2025","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"36","key":"pone.0350186.ref005","article-title":"Latent Tuberculosis Infection Screening and Treatment in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Release Assay Cohort","volume":"36","author":"HW Kim","year":"2021","journal-title":"J Korean Med Sci"},{"key":"pone.0350186.ref006","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0","author":"U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute","year":"2017"},{"key":"pone.0350186.ref007","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"issue":"6","key":"pone.0350186.ref008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002824","article-title":"Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries","volume":"16","author":"JR Campbell","year":"2019","journal-title":"PLoS Med"},{"issue":"12","key":"pone.0350186.ref009","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/cid\/ciz188","article-title":"Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort Study","volume":"69","author":"LA Ronald","year":"2019","journal-title":"Clin Infect Dis"},{"key":"pone.0350186.ref010","doi-asserted-by":"crossref","first-page":"1066269","DOI":"10.3389\/fpubh.2022.1066269","article-title":"Prevalence of latent tuberculosis infection among participants of the national LTBI screening program in South Korea - A problem of low coverage rate with current LTBI strategy","volume":"10","author":"HW Kim","year":"2023","journal-title":"Front Public Health"},{"issue":"10010","key":"pone.0350186.ref011","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/S0140-6736(15)00323-2","article-title":"Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection","volume":"386","author":"MX Rangaka","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"pone.0350186.ref012","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1681\/ASN.0000000621","article-title":"Tuberculosis in the US Kidney Failure Population","volume":"36","author":"KR Schildknecht","year":"2025","journal-title":"J Am Soc Nephrol"},{"issue":"53","key":"pone.0350186.ref013","article-title":"End-stage Renal Disease and Risk of Active Tuberculosis: a Nationwide Population-Based Cohort Study","volume":"33","author":"J Min","year":"2018","journal-title":"J Korean Med Sci"},{"issue":"1","key":"pone.0350186.ref014","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12879-022-07039-5","article-title":"Effect of chronic kidney disease on all-cause mortality in tuberculosis disease: an Australian cohort study","volume":"22","author":"BZ Carr","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"2","key":"pone.0350186.ref015","doi-asserted-by":"crossref","first-page":"2392883","DOI":"10.1080\/0886022X.2024.2392883","article-title":"Effect of chronic kidney disease on adverse drug reactions to anti-tubercular treatment: a retrospective cohort study","volume":"46","author":"D Datta","year":"2024","journal-title":"Ren Fail"},{"issue":"5","key":"pone.0350186.ref016","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.ajkd.2020.06.017","article-title":"Latent Tuberculosis Therapy Outcomes in Dialysis Patients: A Retrospective Cohort","volume":"77","author":"LY Chiang","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"pone.0350186.ref017","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf197","article-title":"Screening for latent tuberculosis infection in patients with chronic kidney disease: a review of evidence and current practice in the UK","volume":"18","author":"J Sturman","year":"2025","journal-title":"Clin Kidney J"},{"issue":"20","key":"pone.0350186.ref018","article-title":"Latent Tuberculosis Cascade of Care Among Healthcare Workers: A Nationwide Cohort Analysis in Korea Between 2017 and 2018","volume":"37","author":"J Min","year":"2022","journal-title":"J Korean Med Sci"},{"key":"pone.0350186.ref019","article-title":"The cascade of care for latent tuberculosis infection in congregate settings: A national cohort analysis, Korea, 2017\u20132018","volume":"9","author":"J Min","year":"2022","journal-title":"Frontiers in Medicine"},{"issue":"6","key":"pone.0350186.ref020","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02180-2018","article-title":"New short regimens for latent tuberculosis treatment: safety first!","volume":"52","author":"D Menzies","year":"2018","journal-title":"European Respiratory Journal"},{"issue":"10","key":"pone.0350186.ref021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276387","article-title":"Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial)","volume":"17","author":"M Santin","year":"2022","journal-title":"PLoS One"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:28:16Z","timestamp":1781026096000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350186"}},"subtitle":[],"editor":[{"given":"Violet","family":"Chihota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350186","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]}}}